NCT01211964View on ClinicalTrials.gov

LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Healthy

Interventions

DRUG

LEO 22811

Oral administration of solution and tablet.

Trial Locations (1)

Unknown

Covance Clinical Research Unit Ltd., Leeds

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY